nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C8—Vismodegib—skin cancer	0.207	0.284	CbGbCtD
Candesartan—CYP2C9—Vismodegib—skin cancer	0.144	0.198	CbGbCtD
Candesartan—ABCB1—Vismodegib—skin cancer	0.14	0.193	CbGbCtD
Candesartan—ABCB1—Dactinomycin—skin cancer	0.0735	0.101	CbGbCtD
Candesartan—CYP2C8—Fluorouracil—skin cancer	0.0734	0.101	CbGbCtD
Candesartan—CYP2C9—Fluorouracil—skin cancer	0.0512	0.0705	CbGbCtD
Candesartan—ABCB1—Docetaxel—skin cancer	0.0379	0.0522	CbGbCtD
Candesartan—AGTR1—endothelium—skin cancer	0.00358	0.115	CbGeAlD
Candesartan—AGTR1—blood vessel—skin cancer	0.00331	0.106	CbGeAlD
Candesartan—AGTR1—nipple—skin cancer	0.00239	0.0768	CbGeAlD
Candesartan—AGTR1—neck—skin cancer	0.00236	0.076	CbGeAlD
Candesartan—Upper respiratory tract infection—Imiquimod—skin cancer	0.00183	0.00756	CcSEcCtD
Candesartan—Oedema peripheral—Vemurafenib—skin cancer	0.00182	0.00752	CcSEcCtD
Candesartan—Gastrointestinal pain—Vismodegib—skin cancer	0.00174	0.00718	CcSEcCtD
Candesartan—Acute coronary syndrome—Imiquimod—skin cancer	0.00173	0.00715	CcSEcCtD
Candesartan—Myocardial infarction—Imiquimod—skin cancer	0.00172	0.00711	CcSEcCtD
Candesartan—AGTR1—connective tissue—skin cancer	0.00169	0.0545	CbGeAlD
Candesartan—Abdominal pain—Vismodegib—skin cancer	0.00168	0.00694	CcSEcCtD
Candesartan—Sinusitis—Imiquimod—skin cancer	0.00165	0.00681	CcSEcCtD
Candesartan—Malnutrition—Vemurafenib—skin cancer	0.00161	0.00665	CcSEcCtD
Candesartan—AGTR1—epithelium—skin cancer	0.00161	0.0517	CbGeAlD
Candesartan—Haemoglobin—Imiquimod—skin cancer	0.00159	0.00655	CcSEcCtD
Candesartan—Rhinitis—Imiquimod—skin cancer	0.00158	0.00653	CcSEcCtD
Candesartan—Haemorrhage—Imiquimod—skin cancer	0.00158	0.00651	CcSEcCtD
Candesartan—PTGS1—endothelium—skin cancer	0.00158	0.0507	CbGeAlD
Candesartan—Pharyngitis—Imiquimod—skin cancer	0.00157	0.00646	CcSEcCtD
Candesartan—Urinary tract disorder—Imiquimod—skin cancer	0.00156	0.00643	CcSEcCtD
Candesartan—Back pain—Vemurafenib—skin cancer	0.00156	0.00643	CcSEcCtD
Candesartan—Urethral disorder—Imiquimod—skin cancer	0.00155	0.00638	CcSEcCtD
Candesartan—Gastroenteritis—Temozolomide—skin cancer	0.00154	0.00636	CcSEcCtD
Candesartan—Asthenia—Vismodegib—skin cancer	0.00153	0.0063	CcSEcCtD
Candesartan—Pruritus—Vismodegib—skin cancer	0.00151	0.00621	CcSEcCtD
Candesartan—Diarrhoea—Vismodegib—skin cancer	0.00146	0.00601	CcSEcCtD
Candesartan—PTGS1—blood vessel—skin cancer	0.00145	0.0467	CbGeAlD
Candesartan—Cough—Vemurafenib—skin cancer	0.00141	0.0058	CcSEcCtD
Candesartan—Mental disorder—Imiquimod—skin cancer	0.00138	0.00571	CcSEcCtD
Candesartan—Malnutrition—Imiquimod—skin cancer	0.00137	0.00567	CcSEcCtD
Candesartan—Arthralgia—Vemurafenib—skin cancer	0.00137	0.00566	CcSEcCtD
Candesartan—Myalgia—Vemurafenib—skin cancer	0.00137	0.00566	CcSEcCtD
Candesartan—Vomiting—Vismodegib—skin cancer	0.00135	0.00558	CcSEcCtD
Candesartan—Rash—Vismodegib—skin cancer	0.00134	0.00554	CcSEcCtD
Candesartan—Dermatitis—Vismodegib—skin cancer	0.00134	0.00553	CcSEcCtD
Candesartan—Back pain—Imiquimod—skin cancer	0.00133	0.00548	CcSEcCtD
Candesartan—Blood bilirubin increased—Docetaxel—skin cancer	0.00132	0.00546	CcSEcCtD
Candesartan—Cardiac failure—Fluorouracil—skin cancer	0.00129	0.00533	CcSEcCtD
Candesartan—Nausea—Vismodegib—skin cancer	0.00126	0.00522	CcSEcCtD
Candesartan—Angioedema—Imiquimod—skin cancer	0.00126	0.00518	CcSEcCtD
Candesartan—AGTR1—lymphoid tissue—skin cancer	0.00124	0.0398	CbGeAlD
Candesartan—Acute coronary syndrome—Bleomycin—skin cancer	0.00123	0.00508	CcSEcCtD
Candesartan—Hypotension—Vemurafenib—skin cancer	0.00123	0.00507	CcSEcCtD
Candesartan—Myocardial infarction—Bleomycin—skin cancer	0.00122	0.00505	CcSEcCtD
Candesartan—Neutropenia—Dactinomycin—skin cancer	0.00122	0.00504	CcSEcCtD
Candesartan—Palpitations—Imiquimod—skin cancer	0.00121	0.00501	CcSEcCtD
Candesartan—Cough—Imiquimod—skin cancer	0.0012	0.00495	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.0012	0.00494	CcSEcCtD
Candesartan—AGTR1—female reproductive system—skin cancer	0.0012	0.0384	CbGeAlD
Candesartan—Haematuria—Bleomycin—skin cancer	0.00119	0.00491	CcSEcCtD
Candesartan—Hypertension—Imiquimod—skin cancer	0.00119	0.00489	CcSEcCtD
Candesartan—Myalgia—Imiquimod—skin cancer	0.00117	0.00483	CcSEcCtD
Candesartan—Arthralgia—Imiquimod—skin cancer	0.00117	0.00483	CcSEcCtD
Candesartan—Chest pain—Imiquimod—skin cancer	0.00117	0.00483	CcSEcCtD
Candesartan—Anxiety—Imiquimod—skin cancer	0.00117	0.00481	CcSEcCtD
Candesartan—Sweating increased—Temozolomide—skin cancer	0.00115	0.00475	CcSEcCtD
Candesartan—Bronchitis—Temozolomide—skin cancer	0.00114	0.00469	CcSEcCtD
Candesartan—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00113	0.00468	CcSEcCtD
Candesartan—Fatigue—Vemurafenib—skin cancer	0.00113	0.00468	CcSEcCtD
Candesartan—Haemoglobin—Bleomycin—skin cancer	0.00113	0.00465	CcSEcCtD
Candesartan—Haemorrhage—Bleomycin—skin cancer	0.00112	0.00463	CcSEcCtD
Candesartan—Neutropenia—Temozolomide—skin cancer	0.0011	0.00456	CcSEcCtD
Candesartan—Upper respiratory tract infection—Temozolomide—skin cancer	0.0011	0.00453	CcSEcCtD
Candesartan—Tachycardia—Imiquimod—skin cancer	0.00109	0.00452	CcSEcCtD
Candesartan—Agranulocytosis—Dactinomycin—skin cancer	0.00109	0.00449	CcSEcCtD
Candesartan—Hyperhidrosis—Imiquimod—skin cancer	0.00108	0.00447	CcSEcCtD
Candesartan—Hyperglycaemia—Temozolomide—skin cancer	0.00107	0.0044	CcSEcCtD
Candesartan—Angina pectoris—Fluorouracil—skin cancer	0.00106	0.00438	CcSEcCtD
Candesartan—PTGS1—nipple—skin cancer	0.00105	0.0338	CbGeAlD
Candesartan—Hepatitis—Dactinomycin—skin cancer	0.00105	0.00431	CcSEcCtD
Candesartan—Body temperature increased—Vemurafenib—skin cancer	0.00104	0.00429	CcSEcCtD
Candesartan—Pharyngitis—Dactinomycin—skin cancer	0.00104	0.00428	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00102	0.00422	CcSEcCtD
Candesartan—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00101	0.00418	CcSEcCtD
Candesartan—Paraesthesia—Imiquimod—skin cancer	0.00101	0.00415	CcSEcCtD
Candesartan—Cardiac failure congestive—Docetaxel—skin cancer	0.001	0.00414	CcSEcCtD
Candesartan—Dyspnoea—Imiquimod—skin cancer	0.000999	0.00412	CcSEcCtD
Candesartan—AGTR1—head—skin cancer	0.000998	0.0321	CbGeAlD
Candesartan—Somnolence—Imiquimod—skin cancer	0.000997	0.00411	CcSEcCtD
Candesartan—Sinusitis—Temozolomide—skin cancer	0.000988	0.00408	CcSEcCtD
Candesartan—Dyspepsia—Imiquimod—skin cancer	0.000987	0.00407	CcSEcCtD
Candesartan—Gastrointestinal disorder—Imiquimod—skin cancer	0.000968	0.00399	CcSEcCtD
Candesartan—Fatigue—Imiquimod—skin cancer	0.000967	0.00399	CcSEcCtD
Candesartan—Acute coronary syndrome—Fluorouracil—skin cancer	0.000957	0.00395	CcSEcCtD
Candesartan—Renal impairment—Docetaxel—skin cancer	0.000955	0.00394	CcSEcCtD
Candesartan—Myocardial infarction—Fluorouracil—skin cancer	0.000951	0.00393	CcSEcCtD
Candesartan—Haemoglobin—Temozolomide—skin cancer	0.00095	0.00392	CcSEcCtD
Candesartan—Haemorrhage—Temozolomide—skin cancer	0.000946	0.0039	CcSEcCtD
Candesartan—Hepatitis—Temozolomide—skin cancer	0.000946	0.0039	CcSEcCtD
Candesartan—Asthenia—Vemurafenib—skin cancer	0.000943	0.00389	CcSEcCtD
Candesartan—Pharyngitis—Temozolomide—skin cancer	0.000939	0.00387	CcSEcCtD
Candesartan—Urinary tract disorder—Temozolomide—skin cancer	0.000934	0.00385	CcSEcCtD
Candesartan—Oedema peripheral—Temozolomide—skin cancer	0.000932	0.00384	CcSEcCtD
Candesartan—Cardiac failure—Docetaxel—skin cancer	0.000931	0.00384	CcSEcCtD
Candesartan—Pruritus—Vemurafenib—skin cancer	0.00093	0.00384	CcSEcCtD
Candesartan—Urethral disorder—Temozolomide—skin cancer	0.000927	0.00383	CcSEcCtD
Candesartan—Gastrointestinal pain—Imiquimod—skin cancer	0.000917	0.00378	CcSEcCtD
Candesartan—Epistaxis—Fluorouracil—skin cancer	0.000915	0.00378	CcSEcCtD
Candesartan—Hyponatraemia—Docetaxel—skin cancer	0.000913	0.00377	CcSEcCtD
Candesartan—Sinusitis—Fluorouracil—skin cancer	0.000911	0.00376	CcSEcCtD
Candesartan—Agranulocytosis—Fluorouracil—skin cancer	0.000906	0.00374	CcSEcCtD
Candesartan—Anaemia—Bleomycin—skin cancer	0.000902	0.00372	CcSEcCtD
Candesartan—Diarrhoea—Vemurafenib—skin cancer	0.000899	0.00371	CcSEcCtD
Candesartan—Urticaria—Imiquimod—skin cancer	0.000891	0.00368	CcSEcCtD
Candesartan—Body temperature increased—Imiquimod—skin cancer	0.000886	0.00366	CcSEcCtD
Candesartan—Abdominal pain—Imiquimod—skin cancer	0.000886	0.00366	CcSEcCtD
Candesartan—Haemoglobin—Fluorouracil—skin cancer	0.000876	0.00361	CcSEcCtD
Candesartan—Leukopenia—Bleomycin—skin cancer	0.000874	0.00361	CcSEcCtD
Candesartan—Rhinitis—Fluorouracil—skin cancer	0.000873	0.0036	CcSEcCtD
Candesartan—Haemorrhage—Fluorouracil—skin cancer	0.000871	0.0036	CcSEcCtD
Candesartan—Dizziness—Vemurafenib—skin cancer	0.000869	0.00359	CcSEcCtD
Candesartan—Pharyngitis—Fluorouracil—skin cancer	0.000865	0.00357	CcSEcCtD
Candesartan—ABCB1—blood vessel—skin cancer	0.000859	0.0276	CbGeAlD
Candesartan—Cough—Bleomycin—skin cancer	0.000852	0.00351	CcSEcCtD
Candesartan—Anaemia—Dactinomycin—skin cancer	0.000841	0.00347	CcSEcCtD
Candesartan—Vomiting—Vemurafenib—skin cancer	0.000836	0.00345	CcSEcCtD
Candesartan—Chest pain—Bleomycin—skin cancer	0.000831	0.00343	CcSEcCtD
Candesartan—Myalgia—Bleomycin—skin cancer	0.000831	0.00343	CcSEcCtD
Candesartan—Rash—Vemurafenib—skin cancer	0.000829	0.00342	CcSEcCtD
Candesartan—Mental disorder—Temozolomide—skin cancer	0.000828	0.00342	CcSEcCtD
Candesartan—Dermatitis—Vemurafenib—skin cancer	0.000828	0.00342	CcSEcCtD
Candesartan—Headache—Vemurafenib—skin cancer	0.000824	0.0034	CcSEcCtD
Candesartan—Malnutrition—Temozolomide—skin cancer	0.000823	0.0034	CcSEcCtD
Candesartan—Leukopenia—Dactinomycin—skin cancer	0.000815	0.00336	CcSEcCtD
Candesartan—Asthenia—Imiquimod—skin cancer	0.000804	0.00332	CcSEcCtD
Candesartan—Back pain—Temozolomide—skin cancer	0.000796	0.00329	CcSEcCtD
Candesartan—Pruritus—Imiquimod—skin cancer	0.000793	0.00327	CcSEcCtD
Candesartan—Nausea—Vemurafenib—skin cancer	0.000781	0.00322	CcSEcCtD
Candesartan—Thrombocytopenia—Bleomycin—skin cancer	0.00078	0.00322	CcSEcCtD
Candesartan—Myalgia—Dactinomycin—skin cancer	0.000775	0.0032	CcSEcCtD
Candesartan—Diarrhoea—Imiquimod—skin cancer	0.000767	0.00317	CcSEcCtD
Candesartan—Angina pectoris—Docetaxel—skin cancer	0.000765	0.00316	CcSEcCtD
Candesartan—Anaemia—Temozolomide—skin cancer	0.000761	0.00314	CcSEcCtD
Candesartan—Angioedema—Temozolomide—skin cancer	0.000752	0.0031	CcSEcCtD
Candesartan—PTGS1—connective tissue—skin cancer	0.000745	0.024	CbGeAlD
Candesartan—Hypotension—Bleomycin—skin cancer	0.000744	0.00307	CcSEcCtD
Candesartan—Dizziness—Imiquimod—skin cancer	0.000741	0.00306	CcSEcCtD
Candesartan—Vertigo—Temozolomide—skin cancer	0.00074	0.00305	CcSEcCtD
Candesartan—Leukopenia—Temozolomide—skin cancer	0.000737	0.00304	CcSEcCtD
Candesartan—Neutropenia—Docetaxel—skin cancer	0.000735	0.00303	CcSEcCtD
Candesartan—Palpitations—Temozolomide—skin cancer	0.000727	0.003	CcSEcCtD
Candesartan—Thrombocytopenia—Dactinomycin—skin cancer	0.000727	0.003	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000726	0.00299	CcSEcCtD
Candesartan—Cough—Temozolomide—skin cancer	0.000718	0.00296	CcSEcCtD
Candesartan—Paraesthesia—Bleomycin—skin cancer	0.000715	0.00295	CcSEcCtD
Candesartan—Vomiting—Imiquimod—skin cancer	0.000713	0.00294	CcSEcCtD
Candesartan—Hypertension—Temozolomide—skin cancer	0.000711	0.00293	CcSEcCtD
Candesartan—Dyspnoea—Bleomycin—skin cancer	0.00071	0.00293	CcSEcCtD
Candesartan—PTGS1—epithelium—skin cancer	0.000707	0.0227	CbGeAlD
Candesartan—Rash—Imiquimod—skin cancer	0.000707	0.00292	CcSEcCtD
Candesartan—Dermatitis—Imiquimod—skin cancer	0.000706	0.00291	CcSEcCtD
Candesartan—Headache—Imiquimod—skin cancer	0.000702	0.0029	CcSEcCtD
Candesartan—Anaemia—Fluorouracil—skin cancer	0.000701	0.00289	CcSEcCtD
Candesartan—Arthralgia—Temozolomide—skin cancer	0.000701	0.00289	CcSEcCtD
Candesartan—Myalgia—Temozolomide—skin cancer	0.000701	0.00289	CcSEcCtD
Candesartan—AGTR1—lymph node—skin cancer	0.000699	0.0225	CbGeAlD
Candesartan—Anxiety—Temozolomide—skin cancer	0.000698	0.00288	CcSEcCtD
Candesartan—Acute coronary syndrome—Docetaxel—skin cancer	0.000691	0.00285	CcSEcCtD
Candesartan—Renal failure—Docetaxel—skin cancer	0.000689	0.00284	CcSEcCtD
Candesartan—Myocardial infarction—Docetaxel—skin cancer	0.000687	0.00283	CcSEcCtD
Candesartan—Leukopenia—Fluorouracil—skin cancer	0.000679	0.0028	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000677	0.00279	CcSEcCtD
Candesartan—PTGS1—skin of body—skin cancer	0.000673	0.0216	CbGeAlD
Candesartan—Nausea—Imiquimod—skin cancer	0.000666	0.00275	CcSEcCtD
Candesartan—Epistaxis—Docetaxel—skin cancer	0.000661	0.00273	CcSEcCtD
Candesartan—Thrombocytopenia—Temozolomide—skin cancer	0.000658	0.00271	CcSEcCtD
Candesartan—Agranulocytosis—Docetaxel—skin cancer	0.000654	0.0027	CcSEcCtD
Candesartan—Hyperhidrosis—Temozolomide—skin cancer	0.000649	0.00268	CcSEcCtD
Candesartan—CYP2C8—female reproductive system—skin cancer	0.000648	0.0208	CbGeAlD
Candesartan—Chest pain—Fluorouracil—skin cancer	0.000646	0.00266	CcSEcCtD
Candesartan—Myalgia—Fluorouracil—skin cancer	0.000646	0.00266	CcSEcCtD
Candesartan—Fatigue—Dactinomycin—skin cancer	0.00064	0.00264	CcSEcCtD
Candesartan—Urticaria—Bleomycin—skin cancer	0.000633	0.00261	CcSEcCtD
Candesartan—Haemoglobin—Docetaxel—skin cancer	0.000632	0.00261	CcSEcCtD
Candesartan—Rhinitis—Docetaxel—skin cancer	0.00063	0.0026	CcSEcCtD
Candesartan—Body temperature increased—Bleomycin—skin cancer	0.00063	0.0026	CcSEcCtD
Candesartan—Haemorrhage—Docetaxel—skin cancer	0.000629	0.0026	CcSEcCtD
Candesartan—Hepatitis—Docetaxel—skin cancer	0.000629	0.0026	CcSEcCtD
Candesartan—Pharyngitis—Docetaxel—skin cancer	0.000624	0.00258	CcSEcCtD
Candesartan—Urinary tract disorder—Docetaxel—skin cancer	0.000621	0.00256	CcSEcCtD
Candesartan—Oedema peripheral—Docetaxel—skin cancer	0.00062	0.00256	CcSEcCtD
Candesartan—Urethral disorder—Docetaxel—skin cancer	0.000616	0.00254	CcSEcCtD
Candesartan—PTGS1—mammalian vulva—skin cancer	0.000614	0.0197	CbGeAlD
Candesartan—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000612	0.00253	CcSEcCtD
Candesartan—Gastrointestinal pain—Dactinomycin—skin cancer	0.000607	0.00251	CcSEcCtD
Candesartan—Thrombocytopenia—Fluorouracil—skin cancer	0.000606	0.0025	CcSEcCtD
Candesartan—Tachycardia—Fluorouracil—skin cancer	0.000604	0.00249	CcSEcCtD
Candesartan—Paraesthesia—Temozolomide—skin cancer	0.000603	0.00249	CcSEcCtD
Candesartan—Dyspnoea—Temozolomide—skin cancer	0.000599	0.00247	CcSEcCtD
Candesartan—Somnolence—Temozolomide—skin cancer	0.000597	0.00246	CcSEcCtD
Candesartan—Dyspepsia—Temozolomide—skin cancer	0.000591	0.00244	CcSEcCtD
Candesartan—Body temperature increased—Dactinomycin—skin cancer	0.000587	0.00242	CcSEcCtD
Candesartan—Abdominal pain—Dactinomycin—skin cancer	0.000587	0.00242	CcSEcCtD
Candesartan—Gastrointestinal disorder—Temozolomide—skin cancer	0.00058	0.00239	CcSEcCtD
Candesartan—Fatigue—Temozolomide—skin cancer	0.000579	0.00239	CcSEcCtD
Candesartan—Hypotension—Fluorouracil—skin cancer	0.000578	0.00239	CcSEcCtD
Candesartan—CYP2C9—female reproductive system—skin cancer	0.000576	0.0185	CbGeAlD
Candesartan—Asthenia—Bleomycin—skin cancer	0.000571	0.00236	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000564	0.00233	CcSEcCtD
Candesartan—Pruritus—Bleomycin—skin cancer	0.000563	0.00233	CcSEcCtD
Candesartan—Paraesthesia—Fluorouracil—skin cancer	0.000556	0.00229	CcSEcCtD
Candesartan—Dyspnoea—Fluorouracil—skin cancer	0.000552	0.00228	CcSEcCtD
Candesartan—Mental disorder—Docetaxel—skin cancer	0.000551	0.00227	CcSEcCtD
Candesartan—Somnolence—Fluorouracil—skin cancer	0.00055	0.00227	CcSEcCtD
Candesartan—Gastrointestinal pain—Temozolomide—skin cancer	0.000549	0.00227	CcSEcCtD
Candesartan—Malnutrition—Docetaxel—skin cancer	0.000547	0.00226	CcSEcCtD
Candesartan—Dyspepsia—Fluorouracil—skin cancer	0.000545	0.00225	CcSEcCtD
Candesartan—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000534	0.00221	CcSEcCtD
Candesartan—Urticaria—Temozolomide—skin cancer	0.000534	0.0022	CcSEcCtD
Candesartan—Asthenia—Dactinomycin—skin cancer	0.000533	0.0022	CcSEcCtD
Candesartan—Body temperature increased—Temozolomide—skin cancer	0.000531	0.00219	CcSEcCtD
Candesartan—Abdominal pain—Temozolomide—skin cancer	0.000531	0.00219	CcSEcCtD
Candesartan—Back pain—Docetaxel—skin cancer	0.00053	0.00219	CcSEcCtD
Candesartan—PTGS1—female reproductive system—skin cancer	0.000525	0.0169	CbGeAlD
Candesartan—Diarrhoea—Dactinomycin—skin cancer	0.000508	0.0021	CcSEcCtD
Candesartan—Vomiting—Bleomycin—skin cancer	0.000506	0.00209	CcSEcCtD
Candesartan—Anaemia—Docetaxel—skin cancer	0.000506	0.00209	CcSEcCtD
Candesartan—Rash—Bleomycin—skin cancer	0.000502	0.00207	CcSEcCtD
Candesartan—Dermatitis—Bleomycin—skin cancer	0.000502	0.00207	CcSEcCtD
Candesartan—Urticaria—Fluorouracil—skin cancer	0.000492	0.00203	CcSEcCtD
Candesartan—Leukopenia—Docetaxel—skin cancer	0.00049	0.00202	CcSEcCtD
Candesartan—Body temperature increased—Fluorouracil—skin cancer	0.000489	0.00202	CcSEcCtD
Candesartan—Palpitations—Docetaxel—skin cancer	0.000484	0.002	CcSEcCtD
Candesartan—Asthenia—Temozolomide—skin cancer	0.000482	0.00199	CcSEcCtD
Candesartan—Cough—Docetaxel—skin cancer	0.000478	0.00197	CcSEcCtD
Candesartan—Pruritus—Temozolomide—skin cancer	0.000475	0.00196	CcSEcCtD
Candesartan—Nausea—Bleomycin—skin cancer	0.000473	0.00195	CcSEcCtD
Candesartan—Hypertension—Docetaxel—skin cancer	0.000473	0.00195	CcSEcCtD
Candesartan—Vomiting—Dactinomycin—skin cancer	0.000472	0.00195	CcSEcCtD
Candesartan—Rash—Dactinomycin—skin cancer	0.000468	0.00193	CcSEcCtD
Candesartan—Myalgia—Docetaxel—skin cancer	0.000466	0.00192	CcSEcCtD
Candesartan—Chest pain—Docetaxel—skin cancer	0.000466	0.00192	CcSEcCtD
Candesartan—Arthralgia—Docetaxel—skin cancer	0.000466	0.00192	CcSEcCtD
Candesartan—Diarrhoea—Temozolomide—skin cancer	0.00046	0.0019	CcSEcCtD
Candesartan—Dizziness—Temozolomide—skin cancer	0.000444	0.00183	CcSEcCtD
Candesartan—Nausea—Dactinomycin—skin cancer	0.000441	0.00182	CcSEcCtD
Candesartan—PTGS1—head—skin cancer	0.000439	0.0141	CbGeAlD
Candesartan—Pruritus—Fluorouracil—skin cancer	0.000438	0.00181	CcSEcCtD
Candesartan—Thrombocytopenia—Docetaxel—skin cancer	0.000437	0.00181	CcSEcCtD
Candesartan—Tachycardia—Docetaxel—skin cancer	0.000436	0.0018	CcSEcCtD
Candesartan—Vomiting—Temozolomide—skin cancer	0.000427	0.00176	CcSEcCtD
Candesartan—Rash—Temozolomide—skin cancer	0.000424	0.00175	CcSEcCtD
Candesartan—Diarrhoea—Fluorouracil—skin cancer	0.000424	0.00175	CcSEcCtD
Candesartan—Dermatitis—Temozolomide—skin cancer	0.000423	0.00175	CcSEcCtD
Candesartan—Headache—Temozolomide—skin cancer	0.000421	0.00174	CcSEcCtD
Candesartan—ABCB1—epithelium—skin cancer	0.000418	0.0134	CbGeAlD
Candesartan—Hypotension—Docetaxel—skin cancer	0.000417	0.00172	CcSEcCtD
Candesartan—Dizziness—Fluorouracil—skin cancer	0.000409	0.00169	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000407	0.00168	CcSEcCtD
Candesartan—Paraesthesia—Docetaxel—skin cancer	0.000401	0.00166	CcSEcCtD
Candesartan—Nausea—Temozolomide—skin cancer	0.000399	0.00165	CcSEcCtD
Candesartan—Dyspnoea—Docetaxel—skin cancer	0.000398	0.00164	CcSEcCtD
Candesartan—Somnolence—Docetaxel—skin cancer	0.000397	0.00164	CcSEcCtD
Candesartan—Vomiting—Fluorouracil—skin cancer	0.000394	0.00162	CcSEcCtD
Candesartan—Dyspepsia—Docetaxel—skin cancer	0.000393	0.00162	CcSEcCtD
Candesartan—Rash—Fluorouracil—skin cancer	0.00039	0.00161	CcSEcCtD
Candesartan—Dermatitis—Fluorouracil—skin cancer	0.00039	0.00161	CcSEcCtD
Candesartan—Headache—Fluorouracil—skin cancer	0.000388	0.0016	CcSEcCtD
Candesartan—Gastrointestinal disorder—Docetaxel—skin cancer	0.000386	0.00159	CcSEcCtD
Candesartan—Fatigue—Docetaxel—skin cancer	0.000385	0.00159	CcSEcCtD
Candesartan—Nausea—Fluorouracil—skin cancer	0.000368	0.00152	CcSEcCtD
Candesartan—Gastrointestinal pain—Docetaxel—skin cancer	0.000365	0.00151	CcSEcCtD
Candesartan—ABCB1—mammalian vulva—skin cancer	0.000363	0.0117	CbGeAlD
Candesartan—Body temperature increased—Docetaxel—skin cancer	0.000353	0.00146	CcSEcCtD
Candesartan—Abdominal pain—Docetaxel—skin cancer	0.000353	0.00146	CcSEcCtD
Candesartan—ABCB1—lymphoid tissue—skin cancer	0.000322	0.0104	CbGeAlD
Candesartan—Asthenia—Docetaxel—skin cancer	0.000321	0.00132	CcSEcCtD
Candesartan—Pruritus—Docetaxel—skin cancer	0.000316	0.0013	CcSEcCtD
Candesartan—ABCB1—female reproductive system—skin cancer	0.000311	0.00999	CbGeAlD
Candesartan—PTGS1—lymph node—skin cancer	0.000307	0.00988	CbGeAlD
Candesartan—Diarrhoea—Docetaxel—skin cancer	0.000306	0.00126	CcSEcCtD
Candesartan—Dizziness—Docetaxel—skin cancer	0.000295	0.00122	CcSEcCtD
Candesartan—Vomiting—Docetaxel—skin cancer	0.000284	0.00117	CcSEcCtD
Candesartan—Rash—Docetaxel—skin cancer	0.000282	0.00116	CcSEcCtD
Candesartan—Dermatitis—Docetaxel—skin cancer	0.000281	0.00116	CcSEcCtD
Candesartan—Headache—Docetaxel—skin cancer	0.00028	0.00116	CcSEcCtD
Candesartan—Nausea—Docetaxel—skin cancer	0.000265	0.0011	CcSEcCtD
Candesartan—ABCB1—head—skin cancer	0.00026	0.00834	CbGeAlD
Candesartan—ABCB1—lymph node—skin cancer	0.000182	0.00584	CbGeAlD
